Press Releases

Date Title and Summary View
Toggle Summary Oxford Immunotec Reports Second Quarter 2018 Financial Results
Second quarter Tuberculosis (TB) revenue growth of 17%, with record TB revenue in the United States Gross margin improved by 450 basis points compared to prior year period and 630 basis points on a sequential basis Launch of transformative T-Cell Select™ product to enable full automation of T-SPOT
View HTML
Toggle Summary Oxford Immunotec Launches T-Cell Select™ to Enable Full Automation of the T-SPOT®.TB Test, Provides Unrivaled Sample Stability and Simplicity of Blood Collection
OXFORD, United Kingdom and MARLBOROUGH, Mass., July 31, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced the launch of the new CE-marked T-Cell Select kit in Europe and select ROW countries.
View HTML
Toggle Summary Oxford Immunotec Schedules Second Quarter 2018 Earnings Release and Conference Call for July 31, 2018
OXFORD, United Kingdom and MARLBOROUGH, Mass. , July 17, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that it plans to release second quarter 2018 financial results prior to market open on Tuesday, July 31, 2018 . Dr.
View HTML
Toggle Summary Oxford Immunotec Applauds Updated Guidelines from the American Academy of Pediatrics Supporting Expanded Use of the T-SPOT®.TB Test
OXFORD, United Kingdom and MARLBOROUGH, Mass. , June 05, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that it applauds updated guidelines from the American Academy of Pediatrics (AAP) on screening for latent
View HTML
Toggle Summary Oxford Immunotec Announces Data Presentations for T-SPOT®.CMV Test at the 2018 American Transplant Congress
OXFORD, United Kingdom and MARLBOROUGH, Mass. , June 04, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that data from studies utilizing the T-SPOT. CMV test will be presented at the American Transplant Congress (ATC)
View HTML
Toggle Summary Oxford Immunotec to Present at the Jefferies 2018 Healthcare Conference
OXFORD, United Kingdom and MARLBOROUGH, Mass. , May 29, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that Rick Altieri , Chief Financial Officer, will present at the Jefferies 2018 Healthcare Conference on Tuesday,
View HTML
Toggle Summary Oxford Immunotec’s T-SPOT®.TB Test Included in the World Health Organization’s First-Ever Essential Diagnostics List
OXFORD, United Kingdom and MARLBOROUGH, Mass. , May 21, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that the Company’s T-SPOT. TB test for tuberculosis (TB) infection has been included in the World Health
View HTML
Toggle Summary Oxford Immunotec to Present at the 2018 UBS Global Healthcare Conference
OXFORD, United Kingdom and MARLBOROUGH, Mass. , May 16, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that Dr. Peter Wrighton-Smith , Chief Executive Officer, will present at the 2018 UBS Global Healthcare Conference
View HTML
Toggle Summary Oxford Immunotec Reports First Quarter 2018 Financial Results
OXFORD, United Kingdom and MARLBOROUGH, Mass. , May 01, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced first quarter 2018 financial results. “Our first quarter results were in line with our expectations, with
View HTML
Toggle Summary Oxford Immunotec Schedules First Quarter 2018 Earnings Release and Conference Call for May 1, 2018
OXFORD, United Kingdom and MARLBOROUGH, Mass. , April 17, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that it plans to release first quarter 2018 financial results prior to market open on Tuesday, May 1 , 2018.  Dr.
View HTML